Binding and effects of K(ATP) channel openers in the vascular smooth muscle cell line, A10

British Journal of Pharmacology

Volumn 122, Issue 6, 1997, Pages 1119-1126

  Russ, Ulrich ^a   Metzger, Friedrich ^a   Kickenweiz, Elisabeth ^a   Hambrock, Annette ^a   Krippeit Drews, Peter ^a   Quast, Ulrich ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

3H P1075 binding; A10 cells; Glibenclamide; K(ATP) channels; Levcromakalim; P1075; Potassium channel openers; Smooth muscle

Indexed keywords

2 CYANO 1 (1,1 DIMETHYLPROPYL) 3 (3 PYRIDYL)GUANIDINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM); GLIBENCLAMIDE; LEMAKALIM; MINOXIDIL; PINACIDIL; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; POTASSIUM ION; TRITIUM; CROMAKALIM; DRUG DERIVATIVE; GUANIDINE DERIVATIVE; MINOXIDIL SULFATE ESTER; N CYANO N' (1,1 DIMETHYLPROPYL) N'' (3 PYRIDINYL)GUANIDINE; N-CYANO-N'-(1,1-DIMETHYLPROPYL)-N''-(3-PYRIDINYL)GUANIDINE; POTASSIUM CHANNEL BLOCKING AGENT; PYRIDINE DERIVATIVE; VASODILATOR AGENT;

ANIMAL CELL; ARTICLE; BINDING KINETICS; BINDING SITE; CELL MEMBRANE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HYPERPOLARIZATION; MEMBRANE STEADY POTENTIAL; NONHUMAN; POTASSIUM CONDUCTANCE; POTASSIUM CURRENT; PRIORITY JOURNAL; RADIOASSAY; RAT; THORACIC AORTA; VASCULAR SMOOTH MUSCLE; VOLTAGE CLAMP; ANIMAL; BINDING COMPETITION; CELL LINE; CELL MEMBRANE POTENTIAL; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; PATCH CLAMP;

ANIMALS; AORTA, THORACIC; BINDING, COMPETITIVE; CELL LINE; CROMAKALIM; GLYBURIDE; GUANIDINES; MEMBRANE POTENTIALS; MINOXIDIL; MUSCLE, SMOOTH, VASCULAR; PATCH-CLAMP TECHNIQUES; PINACIDIL; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; PYRIDINES; RADIOLIGAND ASSAY; RATS; VASODILATOR AGENTS;

EID: 0030608785     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701514     Document Type: Article

References (43)

1. AGUILAR-BRYAN, L., NICHOLS, C.G., WECHSLER, S.W. CLEMENT, J.P., BOYD, A.E., GONZÁLES, G., HERRERA-SOSA, H., NGUY, K., BRYAN, J. & NELSON, D.A. (1995). Cloning of the β cell high-affinity sulfonylurea receptor: A regulator of insulin secretion. Science, 268, 423-426.
2. ASHCROFT, S.J.H. & ASHCROFT, F.M. (1990). Properties and functions of ATP-sensitive K-channels Cell. Signal., 2, 197-214.
3. BEECH, D.J., ZHANG, H., NAKAO, K. & BOLTON, T.B. (1993). K channel activation by nucleoside diphosphates and its inhibition by glibenclamide in vascular smooth muscle cells. Br. J. Pharmacol., 110, 573-582.
4. BEVINGTON, P.R. (1969). Data Reduction and Error Analysis for the Physical Sciences. pp. 55-65 and 92-118. New York: McGraw-Hill.
5. BONEV, A.D. & NELSON, M.T. (1993). ATP-sensitive potassium channels in smooth muscle cells from guinea pig urinary bladder. Am. J. Physiol., 264, C1190-C1200.
6. + channel openers in rat aorta. J. Biol. Chem., 267, 11689-11692.
7. + channels in humans coronary artery vascular smooth muscle cells. Am. J. Physiol., 273, in press.
8. + current activated by levcromakalim in isolated pulmonary arterial myocytes. J. Membrane Biol., 140, 205-213.
9. ATP channel subunits. Neuron, 18, 827-838.
10. DART, C. & STANDEN, N.B. (1993). Adenosine-activated potassium current in smooth muscle cells isolated from the pig coronary artery. J. Physiol., 471, 767-786.
11. DRAPER, N.B. & SMITH, H. (1981). Applied Regression Analysis. pp. 85-96, 458-517. New York: Wiley.
12. EDWARDS, G. & WESTON, A.H. (1993). The pharmacology of ATP-sensitive potassium channels. Annu. Rev. Pharmacol. Toxicol., 33, 597-637.
13. ATP channel as a receptor for potassium channel openers. J. Biol. Chem., 271, 8796-8799.
14. GILLES, K.D. (1995). Techniques for membrane capacitance measurements. In Single-Channel Recording. Second edition, ed. Sakmann, B. & Neher, E. pp. 155-198. New York: Plenum Publishing Corporation.
15. HAMILL, O.P., MARTY, A., NEHER, E., SAKMANN, B. & SIGWORTH, F.J. (1981). Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch., 391, 85-100.
16. HEINEMANN, S.H. (1995). Guide to data acquisition and analysis. In Single-Channel Recording. Second edition, ed. Sakmann, B. & Neher, E. pp. 53-91. New York: Plenum Publishing Corporation.
17. HILLE, B. (1992). Ionic Channels of Excitable Membranes. Second edition, Sunderland, Massachusetts: Sinauer Associates Inc.
18. + channel opener acts as a potent Cl-channel inhibitor in vascular smooth muscle cells. J. Membrane Biol., 137, 59-70.
19. KATP: An inward rectifier subunit plus the sulfonylurea receptor. Science, 270, 1166-1170.
20. + channels. Neuron, 16, 1011-1017.
21. + channel. J. Biol. Chem., 217, 24321-24324.
22. + channels in a vascular smooth muscle cell line. Naunyn-Schmiedeberg's Arch. Pharmacol., 353 (suppl.), R55.
23. KIMES, B.W. & BRANDT, B.L. (1976). Characterization of two putative smooth muscle cell lines from rat thoracic aorta. Exp. Cell Res., 98, 349-366.
24. KORBMACHER, C., HELBIG, H., STAHL, F., CORONEO, M., HALLER, H., LINDSCHAU, C., QUASS, P. & WIEDERHOLT, M. (1989). Continuous membrane voltage recordings in A10 vascular smooth muscle cells: effect of AVP. Am. J. Physiol., 257, C323-C332.
25. LEMOINE, H., MANNHOLD, R. & GRITTNER, D. (1996). Binding studies with potassium channel openers (KCO) in smooth muscle cells of calf coronary artery as compared to rat cardiomyocytes. Naunyn-Schmiedeberg's Arch. Pharmacol., 353 (suppl.), R54.
26. LÖFFLER, C. & QUAST, U. (1997). Pharmacological characterization of the sulphonylurea receptor in rat isolated aorta. Br. J. Pharmacol., 120, 476-480.
27. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. & RANDALL, R.J. (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265-275.
28. + channels, to rat glomerular preparations. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 452-459.
29. NELSON, M.T. & QUAYLE, J.M. (1995). Physiological roles and properties of potassium channels in arterial smooth muscle. Am. J. Physiol., 268, C799-C822.
30. NOACK, T., DEITMER, P., EDWARDS, G. & WESTON, A.H. (1992). Characterization of potassium currents modulates by BRL 38227 in rat portal vein. Br. J. Pharmacol., 106, 717-726.
31. + channel from rat liver and beef heart mitochondria. J. Biol. Chem., 267, 26062-26069.
32. + channels in the kidney. Naunyn Schmiedeberg's Arch. Pharmacol., 354, 213-225.
33. QUAST, U. (1996b). Effects of potassium channel activators in isolated blood vessels. In Potassium Channels and their Modulators: From Synthesis to Clinical Experience, ed. Evans, J.M., Hamilton, T.C., Longman, S.D. & Stemp, G. pp. 173-195. London: Taylor & Francis.
34. 3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers. Mol. Pharmacol., 43, 474-481.
35. 3H]flunitrazepam with the benzodiazepine receptor: evidence for a ligand-induced conformation change. Biochem. Pharmacol., 31, 2761-2768.
36. ATP channels in vascular smooth muscle. Cardiovasc. Res., 28, 797-804.
37. ATP-channel modulators on whole cell ion current in a smooth muscle cell line (A10) compared with binding studies. Naunyn-Schmiedeberg's Arch. Pharmacol., 355 (suppl.), R74.
38. SAKURA, H., ÄMMÄLÄ, C., SMITH, P.A. GRIBBLE, F.M. & ASHCROFT, F.M. (1995). Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic β-cells, brain, heart and skeletal muscle. FEBS Lett., 377, 338-344.
39. SIGWORTH, F.J., AFFOLTER, H. & NEHER, E. (1995). Design of the EPC9, a computer controlled patch-clamp amplifier. 2. Software. J. Neurosci. Meth., 56, 203-215.
40. TALLARIDA, R.J. (1995). Receptor discrimination and control of agonist-antagonist binding. Am. J. Physiol., 269, E379-E391.
41. +-channel activities of cultured smooth muscle cells from porcine coronary artery. Am. J. Physiol., 263, H491-H496.
42. + current in canine coronary smooth muscle cells. Pflügers Arch., 427, 110-120.
43. ZHANG, H.-L. & BOLTON, T.B. (1996). Two types of ATP-sensitive potassium channels in rat portal vein smooth muscle cells. Br. J. Pharmacol., 118, 105-114.